Dr. George Tidmarsh abruptly resigned as head of the FDA's drug center due to serious concerns about his personal conduct. The departure followed a lawsuit by Aurinia Pharmaceuticals, alleging false statements made by Tidmarsh. The FDA has faced several leadership changes and controversies in recent months.